Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
gsk2256098 (1 trial)
vismodegib (erivedge) (1 trial)
Meningioma (Phase 2)
Trials (1 total)
Trial APIs (2 total)